SIT INVESTMENT ASSOCIATES INC
Position in IDXX — Idexx Laboratories Inc /De
CIK 769317
Minneapolis, MN
Position in IDXX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,290,014
-$154,207 QoQ
Shares Held
4,350
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#481
of 1,286 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SIT INVESTMENT ASSOCIATES INC holds $31,339,154 across 6 Diagnostics & Research names. IDXX ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,965 | $12,516,452 | |
| 2 | A |
Agilent Technologies, Inc.
|
65,737 | $8,731,845 | |
| 3 | NTRA |
Natera, Inc.
|
20,288 | $5,507,177 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
This page
|
4,350 | $2,290,014 | |
| 5 | DGX |
Quest Diagnostics Inc
|
10,680 | $2,263,626 | |
| 6 | RVTY |
Revvity, Inc.
|
270 | $30,040 |
All Filings in IDXX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,290,014 | 4,350 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,444,221 | 4,350 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,942,905 | 4,350 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,779,171 | 4,350 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,949,870 | 5,500 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,309,725 | 5,500 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||